MUMBAI, India, May 29 -- Intellectual Property India has published a patent application (202611053241 A) filed by Poornima University; and Dr. Sunita Kumari, Jaipur, Rajasthan, on April 27, for 'device for artificial intelligence-assisted discovery and gemini surfactant-mediated delivery of dna-targeted therapeutic agents.'
Inventor(s) include Dr. Sunita Kumari.
The application for the patent was published on May 29, under issue no. 22/2026.
According to the abstract released by the Intellectual Property India: "The present invention discloses a device for artificial intelligence-assisted discovery and Gemini surfactant-mediated delivery of DNA-targeted therapeutic agents. The device integrates a computational processing unit configured to predict DNA binding affinity, binding mode, and toxicity of candidate molecules with a molecular interaction chamber for experimental validation under controlled conditions. A surfactant synthesis and modulation unit generates Gemini surfactants capable of inducing reversible compaction and decompaction of DNA, thereby regulating accessibility of binding sites. A drug encapsulation unit incorporates selected molecules into supramolecular assemblies, while a delivery control unit enables controlled and stimulus-independent release based on DNA conformational state and surfactant interactions. A feedback unit iteratively refines predictive models using experimental data. The invention provides enhanced specificity, reduced off-target toxicity, and improved therapeutic efficacy, thereby offering a scalable and integrated solution for DNA-targeted drug discovery and delivery in applications including cancer therapy, gene regulation, and antimicrobial treatment."
Disclaimer: Curated by HT Syndication.
